Jill O’Donnell-Tormey, PhD, is the CEO and director of scientific affairs at the Cancer Research Institute.
In this episode, she discusses the history of cancer immunotherapy, recent breakthroughs, and the role that focused ultrasound may play in enhancing immunotherapy treatments.
Researchers used in vivo selection to engineer new adeno-associated virus vectors specifically designed for brain gene therapy delivered with focused ultrasound blood-brain barrier opening.
The newly created gene vectors provided more than a ten-fold improvement in delivering genes to specific regions of the brain.
Ellen Bubrick, MD, associate professor of Neurology at Harvard Medical School, was awarded a Citizens United for Research in Epilepsy (CURE) Epilepsy Catalyst Award.
She has pioneered a potential epilepsy treatment using low-intensity focused ultrasound and will use the $250,000 award to investigate optimal dosing for transcranial ultrasound.
“Cancer immunotherapy is a big word that encompasses a lot of things, but in its basic terms, it's using treatments that capitalize on the natural ability of your immune system to recognize threats and eliminate them.”
‒ Jill O’Donnell-Tormey, PhD, on the Curing with Sound podcast
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
